Product Description
Immunoassay Markets: Strategies and Trends, Forecasts by Application, Technology, Product, User and Country with Multiplex and Point of Care Market Analysis, Executive Guides 2023 - 2027
"Dramatic change for traditional immunoassay technology as new market model creates enormous opportunity….."
Publication date: December 14, 2022
Page count: 403
The workhorse of the diagnostic industry is finding new legs. The COVID-19 pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile 58 companies large and small, working in this area.
All report data is available in Excel format on request with the corporate license.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance and additional specific data is provided without additional charges.
All report data is available in Excel format on request with the corporate license.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School
